$BMRN
BIOMARIN PHARMACEUTICAL INC

2012 Q3 Form 10-Q Financial Statement

#000119312512331653 Filed on August 02, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2012 Q2 2011 Q2
Revenue $128.1M $124.0M $110.6M
YoY Change 12.95% 12.1% 20.25%
Cost Of Revenue $24.62M $23.57M $19.26M
YoY Change 9.69% 22.38% 33.77%
Gross Profit $103.5M $100.4M $91.37M
YoY Change 13.76% 9.93% 17.89%
Gross Profit Margin 80.78% 80.99% 82.59%
Selling, General & Admin $46.34M $51.54M $41.02M
YoY Change 3.25% 25.66% 9.96%
% of Gross Profit 44.77% 51.31% 44.89%
Research & Development $66.21M $77.81M $52.91M
YoY Change 13.03% 47.07% 48.62%
% of Gross Profit 63.97% 77.47% 57.91%
Depreciation & Amortization $8.900M $8.400M $7.400M
YoY Change 9.88% 13.51% 12.12%
% of Gross Profit 8.6% 8.36% 8.1%
Operating Expenses $112.5M $129.4M $93.92M
YoY Change 8.79% 37.72% 28.84%
Operating Profit -$10.49M -$30.95M $768.0K
YoY Change -32.39% -4130.47% -83.3%
Interest Expense $1.837M $1.925M $2.201M
YoY Change -15.27% -12.54% -153.68%
% of Operating Profit 286.59%
Other Income/Expense, Net $100.0K -$200.0K $100.0K
YoY Change -133.33% -300.0%
Pretax Income -$11.76M -$32.42M -$1.173M
YoY Change -40.39% 2663.6% -295.5%
Income Tax -$6.404M -$411.0K $3.904M
% Of Pretax Income
Net Earnings -$5.357M -$32.01M -$5.077M
YoY Change -69.65% 530.41% 915.4%
Net Earnings / Revenue -4.18% -25.81% -4.59%
Basic Earnings Per Share -$0.27
Diluted Earnings Per Share -$43.76K -$0.27 -$45.78K
COMMON SHARES
Basic Shares Outstanding 123.6M shares 117.9M shares 111.1M
Diluted Shares Outstanding 117.9M shares

Balance Sheet

Concept 2012 Q3 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $426.5M $402.6M $258.9M
YoY Change 90.06% 55.5% -23.33%
Cash & Equivalents $181.3M $177.8M $113.0M
Short-Term Investments $245.1M $224.8M $146.0M
Other Short-Term Assets $54.82M $58.07M $31.60M
YoY Change 67.63% 83.78% 89.22%
Inventory $120.8M $120.1M $112.3M
Prepaid Expenses $11.42M $14.87M
Receivables $117.3M $100.8M $106.6M
Other Receivables $9.000M $9.700M $4.600M
Total Short-Term Assets $719.4M $681.5M $514.1M
YoY Change 47.72% 32.57% -1.49%
LONG-TERM ASSETS
Property, Plant & Equipment $273.7M $267.4M $216.5M
YoY Change 2.83% 23.5% 1.83%
Goodwill $51.54M $51.54M
YoY Change
Intangibles $165.6M $168.3M
YoY Change
Long-Term Investments $107.6M $123.2M $154.3M
YoY Change -26.7% -20.16% 30.65%
Other Assets $19.74M $20.06M $240.7M
YoY Change -91.87% -91.67% 1548.63%
Total Long-Term Assets $848.0M $851.0M $766.3M
YoY Change 4.94% 11.05% 65.29%
TOTAL ASSETS
Total Short-Term Assets $719.4M $681.5M $514.1M
Total Long-Term Assets $848.0M $851.0M $766.3M
Total Assets $1.567B $1.533B $1.280B
YoY Change 21.02% 19.69% 29.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.46M $12.50M $7.300M
YoY Change 61.39% 71.25% -24.74%
Accrued Expenses $36.39M $32.45M $58.50M
YoY Change -43.5% -44.53% 3.72%
Deferred Revenue
YoY Change
Short-Term Debt $23.40M $23.40M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $134.9M $120.0M $82.00M
YoY Change 61.98% 46.34% -2.26%
LONG-TERM LIABILITIES
Long-Term Debt $324.9M $324.9M $377.5M
YoY Change -6.72% -13.93% -24.06%
Other Long-Term Liabilities $92.39M $87.24M $52.00M
YoY Change 76.32% 67.77% 107.17%
Total Long-Term Liabilities $92.39M $87.24M $429.5M
YoY Change -76.94% -79.69% -17.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $134.9M $120.0M $82.00M
Total Long-Term Liabilities $92.39M $87.24M $429.5M
Total Liabilities $552.2M $532.1M $548.1M
YoY Change 6.09% -2.92% -11.97%
SHAREHOLDERS EQUITY
Retained Earnings -$486.4M -$481.1M
YoY Change
Common Stock $1.506B $1.483B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.015B $1.000B $732.3M
YoY Change
Total Liabilities & Shareholders Equity $1.567B $1.533B $1.280B
YoY Change 21.02% 19.69% 29.92%

Cashflow Statement

Concept 2012 Q3 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income -$5.357M -$32.01M -$5.077M
YoY Change -69.65% 530.41% 915.4%
Depreciation, Depletion And Amortization $8.900M $8.400M $7.400M
YoY Change 9.88% 13.51% 12.12%
Cash From Operating Activities $14.20M -$1.400M $13.60M
YoY Change 61.36% -110.29% -38.74%
INVESTING ACTIVITIES
Capital Expenditures -$15.00M -$9.500M -$2.000M
YoY Change -73.36% 375.0% -86.84%
Acquisitions
YoY Change
Other Investing Activities -$5.900M -$142.9M $2.600M
YoY Change 210.53% -5596.15% 23.81%
Cash From Investing Activities -$21.00M -$152.3M $700.0K
YoY Change -63.98% -21857.14% -105.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $235.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.30M 249.0M 7.900M
YoY Change 32.05% 3051.9% -459.09%
NET CHANGE
Cash From Operating Activities 14.20M -1.400M 13.60M
Cash From Investing Activities -21.00M -152.3M 700.0K
Cash From Financing Activities 10.30M 249.0M 7.900M
Net Change In Cash 3.500M 95.30M 22.20M
YoY Change -108.39% 329.28% 221.74%
FREE CASH FLOW
Cash From Operating Activities $14.20M -$1.400M $13.60M
Capital Expenditures -$15.00M -$9.500M -$2.000M
Free Cash Flow $29.20M $8.100M $15.60M
YoY Change -55.15% -48.08% -58.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123555244 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112956000
CY2012Q2 us-gaap Goodwill
Goodwill
51543000
CY2012Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
86857000
CY2012Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
143018000
CY2012Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3890000
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
399106000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
21115000
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1483336000
CY2012Q2 us-gaap Other Assets Current
OtherAssetsCurrent
58073000
CY2012Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
9777000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20061000
CY2012Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
34673000
CY2012Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
807000
CY2012Q2 us-gaap Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
7048000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
1000426000
CY2012Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5892000
CY2012Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
75293000
CY2012Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
109000
CY2012Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
61638000
CY2012Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7350000
CY2012Q2 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
-23000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13960000
CY2012Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4075000
CY2012Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
2198000
CY2012Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
300000
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123235882 shares
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
62648000
CY2012Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
169720000
CY2012Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
52321000
CY2012Q2 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
6604000
CY2012Q2 us-gaap Liabilities
Liabilities
532101000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12501000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14869000
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87239000
CY2012Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5165000
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
95463000
CY2012Q2 us-gaap Long Term Investments
LongTermInvestments
121970000
CY2012Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1442000
CY2012Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
177757000
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
220593000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-481079000
CY2012Q2 us-gaap Assets
Assets
1532527000
CY2012Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8235000
CY2012Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
32698000
CY2012Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
324865000
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100750000
CY2012Q2 us-gaap Inventory Net
InventoryNet
120125000
CY2012Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
541396000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1532527000
CY2012Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
50129000
CY2012Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6005000
CY2012Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
23440000
CY2012Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
82863000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177757000
CY2012Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
118242000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123235882 shares
CY2012Q2 us-gaap Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
980000
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168267000
CY2012Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
3357000
CY2012Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2418000
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
346822000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4650000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
975000 shares
CY2012Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
28781000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32449000
CY2012Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
96557000
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
12809000
CY2012Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7864000
CY2012Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
692000
CY2012Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1112000
CY2012Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
12336000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
119997000
CY2012Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
6178000
CY2012Q2 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
5717000
CY2012Q2 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2105000
CY2012Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
63689000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
471000
CY2012Q2 us-gaap Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2
191000
CY2012Q2 us-gaap Short Term Investments
ShortTermInvestments
224829000
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
123000
CY2012Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4210000
CY2012Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
13311000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1303000
CY2012Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13664000
CY2012Q2 us-gaap Land
Land
10056000
CY2012Q2 us-gaap Assets Current
AssetsCurrent
681534000
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
44668000
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131732000
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
267374000
CY2012Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1185000
CY2012Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
346799000
CY2012Q2 bmrn Computer Hardware And Software
ComputerHardwareAndSoftware
51108000
CY2012Q2 bmrn Deferred Compensation Liability Included In Other Long Term Liabilities
DeferredCompensationLiabilityIncludedInOtherLongTermLiabilities
0.93 pure
CY2012Q2 bmrn Contingent Acquisition Consideration Payable Included In Accounts Payable And Accrued Liabilities
ContingentAcquisitionConsiderationPayableIncludedInAccountsPayableAndAccruedLiabilities
0.17 pure
CY2012Q2 bmrn Contingent Acquisition Consideration Payable Included In Other Long Term Liabilities
ContingentAcquisitionConsiderationPayableIncludedInOtherLongTermLiabilities
0.83 pure
CY2012Q2 bmrn Percentage Of Deferred Compensation Asset Included In Other Assets
PercentageOfDeferredCompensationAssetIncludedInOtherAssets
0.95 pure
CY2012Q2 bmrn Available For Sale Securities Debt Maturities Within Four Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinFourYearsAmortizedCost
26388000
CY2012Q2 bmrn Available For Sale Securities Debt Maturities Within Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinThreeYearsAmortizedCost
34060000
CY2012Q2 bmrn Available For Sale Securities Debt Maturities Within Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsAmortizedCost
190911000
CY2012Q2 bmrn Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
3222000
CY2012Q2 bmrn Gross Intangible Assets
GrossIntangibleAssets
181931000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88079000
CY2011Q4 us-gaap Goodwill
Goodwill
51543000
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
41803000
CY2011Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
141484000
CY2011Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5866000
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
384716000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
21115000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1197082000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39753000
CY2011Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
6093000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15495000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
38614000
CY2011Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
289000
CY2011Q4 us-gaap Foreign Currency Derivative Assets At Fair Value
ForeignCurrencyDerivativeAssetsAtFairValue
6682000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
773048000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
5555000
CY2011Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
72039000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
196000
CY2011Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
55436000
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9259000
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
70000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
713000
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17619000
CY2011Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3505000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2
231000
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
180277000
CY2011Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2991000
CY2011Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1663000
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
243135000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4887000
CY2011Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
33059000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23849000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114789732 shares
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
75903000
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
70744000
CY2011Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
51275000
CY2011Q4 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
3935000
CY2011Q4 us-gaap Liabilities
Liabilities
530633000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12239000
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7551000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
88179000
CY2011Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5165000
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
148872000
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
94385000
CY2011Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3165000
CY2011Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
46272000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
222649000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-425101000
CY2011Q4 us-gaap Assets
Assets
1303681000
CY2011Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
6530000
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
35127000
CY2011Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
348329000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104839000
CY2011Q4 us-gaap Inventory Net
InventoryNet
130118000
CY2011Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
299664000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1303681000
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
49456000
CY2011Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6025000
CY2011Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0
CY2011Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
28941000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46272000
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
118242000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114789732 shares
CY2011Q4 us-gaap Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
220000
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
94125000
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12145000
CY2011Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7679000
CY2011Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
2119000
CY2011Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
342000
CY2011Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8768000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94125000
CY2011Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
4705000
CY2011Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
0
CY2011Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
70396000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
513000
CY2011Q4 us-gaap Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2
35000
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
148820000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
115000
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
950000
CY2011Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
9450000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1300000
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8361000
CY2011Q4 us-gaap Land
Land
10056000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
469802000
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
42070000
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115745000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268971000
CY2011Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
559000
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
243205000
CY2011Q4 bmrn Computer Hardware And Software
ComputerHardwareAndSoftware
48566000
CY2011Q4 bmrn Deferred Compensation Liability Included In Other Long Term Liabilities
DeferredCompensationLiabilityIncludedInOtherLongTermLiabilities
0.93 pure
CY2011Q4 bmrn Contingent Acquisition Consideration Payable Included In Accounts Payable And Accrued Liabilities
ContingentAcquisitionConsiderationPayableIncludedInAccountsPayableAndAccruedLiabilities
0.14 pure
CY2011Q4 bmrn Contingent Acquisition Consideration Payable Included In Other Long Term Liabilities
ContingentAcquisitionConsiderationPayableIncludedInOtherLongTermLiabilities
0.86 pure
CY2011Q4 bmrn Percentage Of Deferred Compensation Asset Included In Other Assets
PercentageOfDeferredCompensationAssetIncludedInOtherAssets
0.96 pure
CY2011Q4 bmrn Available For Sale Securities Debt Maturities Within Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinThreeYearsAmortizedCost
3100000
CY2011Q4 bmrn Available For Sale Securities Debt Maturities Within Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsAmortizedCost
91163000
CY2011Q4 bmrn Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
0
CY2011Q4 bmrn Gross Intangible Assets
GrossIntangibleAssets
188638000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.48 pure
us-gaap Costs And Expenses
CostsAndExpenses
217025000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021 pure
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
569000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
132565000
us-gaap Operating Income Loss
OperatingIncomeLoss
3062000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
218692000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Contracts Revenue
ContractsRevenue
278000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15559000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11578000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
145639000
us-gaap Revenues
Revenues
220087000
us-gaap Depreciation
Depreciation
14700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1248000
us-gaap Share Based Compensation
ShareBasedCompensation
20937000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2687000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
28000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2117000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2601000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1209000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3258000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17116000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10067000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3675000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1580000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2298000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
151000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8151000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
24877000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20030000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-780000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97889000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11135000
us-gaap Cost Of Revenue
CostOfRevenue
40059000
us-gaap Royalty Revenue
RoyaltyRevenue
1117000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20987000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1749000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
471000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2053000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
110884000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6993000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37973000 shares
us-gaap Net Income Loss
NetIncomeLoss
-9448000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
28000
us-gaap Interest Paid Net
InterestPaidNet
3683000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82089000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8668000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
366000
us-gaap Interest Expense
InterestExpense
4364000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
4400000
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
2479000
bmrn Supplemental Accrued Expenses
SupplementalAccruedExpenses
1896000
bmrn Change Of Business Acquisition Contingent Consideration At Fair Value
ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue
4624000
bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.47 pure
bmrn Common Stock Issuable Under Convertible Debt
CommonStockIssuableUnderConvertibleDebt
19130000 shares
bmrn Options To Purchase Common Stock
OptionsToPurchaseCommonStock
17442000 shares
bmrn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
960000 shares
bmrn Potentially Issuable Common Stock For Espp Purchases
PotentiallyIssuableCommonStockForEsppPurchases
269000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8591000
bmrn Non Qualified Deferred Compensation Plan Obligation Using Treasury Method
NonQualifiedDeferredCompensationPlanObligationUsingTreasuryMethod
172000 shares
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
3012000
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2002000
bmrn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValueOfCommonStock
27.41
dei Trading Symbol
TradingSymbol
BMRN
dei Entity Registrant Name
EntityRegistrantName
BIOMARIN PHARMACEUTICAL INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001048477
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.45 pure
us-gaap Costs And Expenses
CostsAndExpenses
293488000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4235000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
212471000
us-gaap Operating Income Loss
OperatingIncomeLoss
-52820000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
239230000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235444000
us-gaap Contracts Revenue
ContractsRevenue
519000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56215000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
27286000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1258000
us-gaap Share Based Compensation
ShareBasedCompensation
23424000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1432000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14176000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
366000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21771000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
7200000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-122345000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1041000
us-gaap Income Taxes Paid
IncomeTaxesPaid
4914000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
6500000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-140000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15663000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
131485000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
6707000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4089000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-56423000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6235000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
393000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1738000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
122991000
CY2012Q2 us-gaap Contracts Revenue
ContractsRevenue
423000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29868000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
151646000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
262421000
us-gaap Cost Of Revenue
CostOfRevenue
40679000
us-gaap Royalty Revenue
RoyaltyRevenue
919000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
84000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2340000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9993000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-632000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
107047000
us-gaap Revenues
Revenues
240668000
us-gaap Depreciation
Depreciation
16800000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
3900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23765000
bmrn Contingent Payments Upon Achievement Of Certain Regulatory And Licensing Milestones
ContingentPaymentsUponAchievementOfCertainRegulatoryAndLicensingMilestones
356800000
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-4376000
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2275000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
116496000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
143000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35520000 shares
us-gaap Net Income Loss
NetIncomeLoss
-55978000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
84000
us-gaap Interest Paid Net
InterestPaidNet
3367000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96787000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2100000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-445000
bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
bmrn Percentage Of Product Revenue Exceeding Consolidated Net Product Revenue
PercentageOfProductRevenueExceedingConsolidatedNetProductRevenue
0.10 pure
bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.42 pure
bmrn Common Stock Issuable Under Convertible Debt
CommonStockIssuableUnderConvertibleDebt
17370000 shares
CY2011Q2 bmrn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
960000 shares
CY2011Q2 bmrn Potentially Issuable Common Stock For Espp Purchases
PotentiallyIssuableCommonStockForEsppPurchases
272000 shares
CY2011Q2 bmrn Non Qualified Deferred Compensation Plan Obligation Using Treasury Method
NonQualifiedDeferredCompensationPlanObligationUsingTreasuryMethod
172000 shares
bmrn Options To Purchase Common Stock
OptionsToPurchaseCommonStock
16529000 shares
bmrn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
1132000 shares
bmrn Potentially Issuable Common Stock For Espp Purchases
PotentiallyIssuableCommonStockForEsppPurchases
256000 shares
CY2011Q2 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
3324000
CY2011Q2 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
1000000
CY2011Q2 bmrn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValueOfCommonStock
27.57
CY2012Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
6707000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Interest Expense
InterestExpense
3872000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
3300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.73
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
1861000
bmrn Supplemental Accrued Expenses
SupplementalAccruedExpenses
1170000
bmrn Change Of Business Acquisition Contingent Consideration At Fair Value
ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue
3942000
bmrn Non Qualified Deferred Compensation Plan Obligation Using Treasury Method
NonQualifiedDeferredCompensationPlanObligationUsingTreasuryMethod
233000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.45 pure
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
154973000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-5077000
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41015000
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3904000
CY2011Q2 us-gaap Interest Expense
InterestExpense
2201000
CY2011Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
2200000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30954000
bmrn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValueOfCommonStock
37.21
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235400000
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6500000 shares
CY2012Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
36.28
CY2011 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
8000000
CY2011 bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 pure
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.48 pure
CY2011Q2 us-gaap Costs And Expenses
CostsAndExpenses
109863000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
768000
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
109616000
CY2011Q2 us-gaap Contracts Revenue
ContractsRevenue
153000
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5213000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2011Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
798000
CY2011Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
129000
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1173000
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52909000
CY2011Q2 us-gaap Cost Of Revenue
CostOfRevenue
19263000
CY2011Q2 us-gaap Royalty Revenue
RoyaltyRevenue
862000
CY2011Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-667000
CY2011Q2 us-gaap Revenues
Revenues
110631000
CY2011Q2 us-gaap Depreciation
Depreciation
7400000
CY2011Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10607000
CY2011Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111114000 shares
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37976000 shares
CY2011Q2 bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
CY2011Q2 bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.46 pure
CY2011Q2 bmrn Common Stock Issuable Under Convertible Debt
CommonStockIssuableUnderConvertibleDebt
19130000 shares
CY2011Q2 bmrn Options To Purchase Common Stock
OptionsToPurchaseCommonStock
17442000 shares
CY2012Q2 bmrn Options To Purchase Common Stock
OptionsToPurchaseCommonStock
16529000 shares
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
536000
CY2012Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-176000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32417000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77812000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
23574000
CY2012Q2 us-gaap Royalty Revenue
RoyaltyRevenue
605000
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
102000
CY2012Q2 us-gaap Revenues
Revenues
124019000
CY2012Q2 us-gaap Depreciation
Depreciation
8400000
CY2012Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
1200000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12637000
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
117912000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35526000 shares
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-32006000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51539000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-411000
CY2012Q2 us-gaap Interest Expense
InterestExpense
1925000
CY2012Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
1700000
CY2012Q2 bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 pure
CY2012Q2 bmrn Sales Revenue Goods Net Percentages
SalesRevenueGoodsNetPercentages
1.00 pure
CY2012Q2 bmrn Percentage Of Net Product Revenue Attributed To Largest Customers
PercentageOfNetProductRevenueAttributedToLargestCustomers
0.43 pure
CY2012Q2 bmrn Common Stock Issuable Under Convertible Debt
CommonStockIssuableUnderConvertibleDebt
17370000 shares
CY2012Q2 bmrn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
1136000 shares
CY2012Q2 bmrn Potentially Issuable Common Stock For Espp Purchases
PotentiallyIssuableCommonStockForEsppPurchases
258000 shares
CY2012Q2 bmrn Non Qualified Deferred Compensation Plan Obligation Using Treasury Method
NonQualifiedDeferredCompensationPlanObligationUsingTreasuryMethod
233000 shares
CY2012Q2 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
-2048000
CY2012Q2 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
1200000
CY2012Q2 bmrn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValueOfCommonStock
37.31

Files In Submission

Name View Source Status
0001193125-12-331653-index-headers.html Edgar Link pending
0001193125-12-331653-index.html Edgar Link pending
0001193125-12-331653.txt Edgar Link pending
0001193125-12-331653-xbrl.zip Edgar Link pending
bmrn-20120630.xml Edgar Link completed
bmrn-20120630.xsd Edgar Link pending
bmrn-20120630_cal.xml Edgar Link unprocessable
bmrn-20120630_def.xml Edgar Link unprocessable
bmrn-20120630_lab.xml Edgar Link unprocessable
bmrn-20120630_pre.xml Edgar Link unprocessable
d370421d10q.htm Edgar Link pending
d370421dex1010.htm Edgar Link pending
d370421dex1011.htm Edgar Link pending
d370421dex1012.htm Edgar Link pending
d370421dex1013.htm Edgar Link pending
d370421dex1014.htm Edgar Link pending
d370421dex311.htm Edgar Link pending
d370421dex312.htm Edgar Link pending
d370421dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending